Allan–Herndon–Dudley syndrome
Overview
Allan–Herndon–Dudley syndrome is a rare genetic brain development disorder caused by mutations in the MCT8 gene, characterized by moderate-to-severe intellectual disability, severe movement issues, and abnormal thyroid hormone blood levels. It affects males almost exclusively due to its X-linked inheritance pattern.
Symptoms
Neurological and Physical Symptoms
Delayed Development: Severe intellectual disability and lack of speech development or aphasia.
Muscle and Movement Changes: Early weak muscle tone in infancy changing into muscle stiffness (spasticity), abnormal muscle wasting (hypoplasia), and involuntary movements like twisting or jerking (dystonia and choreoathetosis).
Mobility Loss: Most affected males never learn to walk or sit unsupported, becoming wheelchair-bound by adulthood.
Joint and Skeletal Issues: Tight joints (contractures), scoliosis, and chest shape abnormalities develop as children grow older.Infant
Feeding Problems: Trouble feeding and failure to thrive or gain weight properly.
Seizures: Late-onset seizures that are often hard to treat with standard medications.
Thyroid Hormone Signs (Thyrotoxicosis)
High Blood T3 Levels: Excess active thyroid hormone in body tissues causing a fast heartbeat (tachycardia), high blood pressure, excessive sweating, low body weight, and irritability.
Causes
Gene Mutation: Changes or pathogenic variants occur in the SLC16A2 Gene, which instructs the body to make the monocarboxylate transporter 8 (MCT8) protein.
Inheritance Pattern: It follows an X-linked recessive pattern, meaning it predominantly affects males who inherit a single altered X chromosome from their mothers.
Blocked Hormone Transport: The faulty MCT8 protein fails to transport the crucial thyroid hormone triiodothyronine (T3) across the blood-brain barrier and into brain cells.
Brain Starvation vs. Body Overload: While the developing brain is starved of necessary T3 hormones (causing severe neurological and developmental deficits), the rest of the body's tissues absorb excess T3, resulting in high blood levels and signs of peripheral toxicity (thyrotoxicosis).
Diagnosis
Infant signs: Low muscle tone (hypotonia), trouble feeding, and poor weight gain.
Development: Severe delays in learning, thinking, and motor skills.
Later signs: Stiff muscles, abnormal movements (dystonia), and sometimes seizures.
High T3: Elevated levels of triiodothyronine in the blood.
Low T4: Decreased levels of thyroxine.
Normal TSH: Thyroid-stimulating hormone stays in the normal or mid-normal range.
SLC16A2 gene test: Blood testing finds a harmful mutation in the SLC16A2 gene (also called MCT8).
Inheritance pattern: It is an X-linked condition, meaning it mostly affects males while females are usually carriers.
Treatment
hydroid Hormone Analogues: Use of tiratricol (Emcitate) helps lower high blood T3 levels and manages high metabolism effects (thyrotoxicosis) like low body weight and fast heart rate. Standard thyroid replacement drugs (like L-T4 or L-T3 alone) are avoided because they can make high T3 toxicity worse.
Movement and Seizure Control: Doctors may prescribe anti-seizure drugs for seizures, or medications like levodopa/carbidopa, baclofen, or anticholinergics to help ease muscle stiffness, rigidity, and movement issues (dystonia or parkinsonism).
Supportive Therapies: Regular physical, occupational, and speech therapy assist with muscle tone, feeding safety, and daily comfort
Multidisciplinary Team: Involves pediatric neurologists, endocrinologists, nutritionists, and physical therapists to handle complex developmental and feeding needs.
Regular Checkups: Routine physical tests monitor growth, spine changes (scoliosis), joint alignment (hip dislocation), and neurological changes.
Type of Doctor Department : A pediatric neurologists, clinical geneticists, and endocrinologists.
.jpg)
Comments
Post a Comment